Taking Your First Dose of Mounjaro: What Really Happens

The 2.5 mg starting dose exists to reduce early side effects, not to deliver therapeutic weight loss — expect adjustment, not transformation.
Side effects are most likely in the first few days after each new dose; they're typically mild, gastrointestinal, and settle within a week or two for most people.
Injection sites (abdomen, thigh or upper arm) should be rotated each week; storing your pen correctly in the fridge (2–8 °C) keeps it stable.
Your prescriber, not this page, decides when and whether your dose increases, never adjust timing or amount without that clinical conversation.

Your first Mounjaro dose is 2.5 mg — a starter strength chosen purely to let your body adjust, not to produce weight loss. That distinction matters, because many people on their first pen worry it isn't working. It is working: it's just doing a different job. Mounjaro is a prescription-only medicine, so your prescriber will have assessed your suitability before this moment arrives. Here's what the evidence and clinical guidance actually say about those first seven days.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The Honest Picture: What the First Seven Days of Mounjaro Actually Look Like

The myth that catches almost everyone out: 2.5 mg should be producing results

The single biggest misconception about starting Mounjaro is that the 2.5 mg pen is doing the same thing as the higher doses, just less of it. That's not quite right. The first four-week pen is there to introduce tirzepatide to your system gradually, reducing the nausea, reflux and stomach discomfort that can hit harder at a therapeutic dose. Think of it as your body learning the medicine before the medicine starts its main work. Most people don't see meaningful weight change at 2.5 mg, and that's expected. The NHS tirzepatide information page confirms that treatment is titrated in steps by the prescriber, with 2.5 mg as the entry point, not the working dose.

This matters practically. If you weigh yourself every morning during your first pen and see nothing move, that's not failure. A question our prescribers hear most weeks is whether the medicine is real or working. It is. The adjustment period is the evidence of that.

Understanding the wider picture of how Mounjaro works (as a dual GIP and GLP-1 receptor agonist) is covered in detail on the Mounjaro treatment page. For now, the key thing is to get the injection done correctly and let the titration schedule unfold as your clinician has planned it.

What you're likely to feel in days one to seven

Most people notice something in the 24 to 48 hours after their first injection. Nausea is the most common; others report a feeling of fullness that arrives quickly at meals, mild indigestion, or occasional loose stools. Some people feel nothing at all, which is equally normal. Fatigue and mild headache turn up too, usually fading by the end of the first week.

These effects are part of how GLP-1-based medicines slow gastric emptying, food moves through the stomach more slowly, and your appetite signals shift. The body notices before you do consciously. The MHRA's Yellow Card scheme is the right place to report any side effects you feel are significant, and it's worth bookmarking before your first dose rather than after.

A few things help during this window. Small meals, eating slowly, staying well hydrated and avoiding very fatty or rich food all reduce the chance of nausea tipping into vomiting. If symptoms are severe (particularly sharp, persistent stomach pain that spreads to your back) contact your GP or call NHS 111 promptly; that pattern can indicate pancreatitis, which requires urgent assessment.

You can read more about the specific experience of the first Mounjaro dose, including practical injection technique, in its own dedicated guide.

Getting the injection right the first time

Mounjaro comes as a pre-filled KwikPen. Each pen delivers four weekly doses, so you won't need a new pen until week five. Before you inject: take the pen out of the fridge and let it sit at room temperature for a few minutes, injecting cold medicine into skin is uncomfortable and unnecessary. Choose your site (abdomen, outer thigh or upper arm), clean it with an alcohol swab, pinch the skin gently if you're lean, and press the pen firmly until you hear the click. Hold for a few seconds. Done.

Rotating sites each week matters, injecting repeatedly into the same spot can cause localised tissue changes over time. Keep a simple note on your phone of which site you used and the day you injected. Some people tie their injection day to a fixed point in the week; injecting on a Sunday evening, for example, means any mild nausea falls on a quieter day rather than a busy morning.

For a step-by-step walkthrough of the injection process, the how to take your first dose of Mounjaro guide goes through each stage. Always check the Patient Information Leaflet supplied with your pen for the exact storage window at room temperature, it differs from the figures sometimes quoted online, and your leaflet is the authoritative source.

Curious about how the 5 mg dose compares in terms of what to expect? The Mounjaro 5 mg page covers what changes when the dose steps up.

After the injection: what comes next

Your second dose lands seven days after the first. The second Mounjaro dose page addresses what's different by week two, in short, you're likely to feel the appetite effects more clearly, and any nausea from week one has usually eased. Your prescriber will review your progress before any dose change; at nume, that review happens before every repeat order, not just at the start.

On cost: if you're at the start of your Mounjaro journey and thinking about what the full titration schedule means financially, the Mounjaro pricing page sets out honest context, including what a legitimate private prescription actually covers. It's a useful read before you commit to the full schedule.

If anything from your first week raises a question (symptoms you're not sure about, uncertainty over your next injection day, or anything your Patient Information Leaflet doesn't quite answer) our aftercare team is available seven days a week. Or, if you haven't yet started treatment and want a clinician to review your suitability, speak to our prescribers through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions